am 580 has been researched along with Cirrhosis in 1 studies
Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kobayashi, Y | 1 |
Tokuda, K | 1 |
Yamashiro, C | 1 |
Higashijima, F | 1 |
Yoshimoto, T | 1 |
Ota, M | 1 |
Ogata, T | 1 |
Ashimori, A | 1 |
Hatano, M | 1 |
Kobayashi, M | 1 |
Uchi, SH | 1 |
Wakuta, M | 1 |
Kimura, K | 1 |
1 other study available for am 580 and Cirrhosis
Article | Year |
---|---|
Inhibition of epithelial-mesenchymal transition in retinal pigment epithelial cells by a retinoic acid receptor-α agonist.
Topics: Actins; Animals; Benzoates; Cell Proliferation; Collagen; Epithelial-Mesenchymal Transition; Female; | 2021 |